Health Trials

Guillain-Barre Syndrome (GBS)

2

Review clinical trials related to Guillain-Barre Syndrome (GBS). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome

The aim of this retrospective observational single-center cohort study is to gain a deeper understanding regarding the frequency, the clinical and electrophysiologic characteristics (e.g., the diagnostic work up), complications, treatment regimes, and their associations with specific courses of disease and outcomes in adult patients with the suspected or proven diagnosis of GBS.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, Basel, SwitzerlandUpdated: Jun 17, 2026Locations: 1
Eligibility criteria

suspected diagnosis of GBS, who have been treated at the University Hospital of...

Patients with documented refusal of the general consent.

Read more
Status: Not yet recruiting

Efgartigimod for the Treatment of Guillain-Barré Syndrome

The goal of this clinical trial is to evaluating the efficacy and safety of efgartigimod in the treatment of Guillain-Barré Syndrome and exploring the immunological mechanisms of efgartigimod therapy in Guillain-Barré Syndrome. The main questions it aims to answer are: Will efgartigimod improve the symptoms of participants? What medical problems do participants have when using efgartigimod? Participants will: On day 1 and day 5 of the treatment period, drug A was administered intravenously. Keep a diary of their symptoms

Participants needed: 20
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Zhongming QiuUpdated: Mar 20, 2025
Eligibility criteria

Aged 18 years or older; [+4]

Patients with GBS symptoms for more than 2 weeks; [+9]

Read more